Delivery Order HHSO100201600005I-75A50120F33010

Award Date 4/7/20
Potential Completion Date 10/7/22
Potential Value $30M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Sharing
Place of Performance
Meriden, CT 06450, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Protein Sciences Corp, a for-profit manufacturer, under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The $357,198.29 Firm Fixed Price delivery order supports Protein Sciences' research, development, manufacturing, and testing of vaccine candidates, antigens,...
This is a delivery order awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Protein Sciences Corporation, a for-profit manufacturer, under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The $1,986,163.00 fixed-price order funds Protein Sciences to conduct research, development, manufacturing, and testing of vaccine candidates, antigens, proteins, seed lots, and assays to support...
This federal contract award, valued at $7,521,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Protein Sciences Corp, a for-profit manufacturer, to conduct research, development, manufacturing, and testing of vaccine candidates, antigens, proteins, seed lots, and assays to support medical countermeasure preparedness against influenza strains and COVID-19. The award is part of the Department of Health and Human Services' (HHS) Office of the Assistant Secretary for...
This is a federal contract award to Protein Sciences Corp, a for-profit vaccine manufacturer, by the U.S. Department of Health and Human Services' (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR). The $2,146,389.00 firm fixed-price contract is a delivery order under ASPR's Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The purpose of the award is for Protein Sciences to manufacture 1 bulk lot of an H7 vaccine. No set-aside designation was...
This $301,152.69 firm fixed price delivery order was awarded to Protein Sciences Corporation by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response on July 30, 2019. It is associated with the larger Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract vehicle. The delivery order is for protein sciences storage and stability services with performance to take place in Meriden, Connecticut and completion scheduled for...
This is a $37,000 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Protein Sciences Corp, a for-profit manufacturer, to provide purified recombinant proteins. The contract has no set-aside designation. Protein Sciences Corp has received multiple federal contract awards from HHS's Office of the Assistant Secretary for Preparedness and Response...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $849,451 firm fixed price delivery order to Protein Sciences Corporation under the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The delivery order is for the manufacture of master/working seed lot(s), research lot(s), and analytical laboratory testing/assay(s) to be performed in Meriden, Connecticut through June 2021. No subcontractors or set aside...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Protein Sciences Corp, a for-profit manufacturer located in Meriden, Connecticut. The $149,999.05 fixed-price contract is for research and development in support of pandemic preparedness, including preclinical and clinical trials of COVID-19 and H7 vaccine candidates, as well as manufacturing and analytical services. Protein Sciences has received multiple past awards from the...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $49,157 delivery order against the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ to Protein Sciences Corporation of Meriden, Connecticut. The firm fixed price order is for claims and will be performed from September 30, 2019 through September 30, 2019 in Meriden, Connecticut. The Pandemic Influenza Preparedness and Response master IDIQ, valued at over $49...
The Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response awarded Protein Sciences Corporation a $125,260 firm fixed price delivery order against the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. This order calls for Protein Sciences to conduct storage and stability testing of antigen final containers in the National Pre-Pandemic Vaccine Stockpile. Specifically, the contractor will test RH7 A Guangdong final...

The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $29.9 million delivery order to Protein Sciences Corporation under the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The delivery order is for non-clinical and Phase I clinical studies of a stabilized pre-fusion trimer of the spike protein COVID-19 vaccine candidate reconstituted with two adjuvants, AS03 and AF03, to be performed in Meriden, Connecticut. The period of performance is from April 7, 2020 through October 7, 2022, with a cost-sharing pricing structure. This delivery order provides nearly $30 million to Protein Sciences Corporation to advance development of a COVID-19 vaccine candidate utilizing the company's recombinant spike protein platform technology, in support of the Department of Health and Human Services' goal to accelerate vaccine and countermeasure development for COVID-19.

Generated 12/16/23, 7:40 PM